1414889-09-0

Basic information

• Product Name: (S)-6-chloro-1-(4-methoxybenzyl)-2-oxo-4-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-4-carbonitrile
• Synonyms: (S)-6-chloro-1-(4-methoxybenzyl)-2-oxo-4-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-4-carbonitrile
• CAS NO: 1414889-09-0
• Molecular Weight: 395.768
• Mol File: 1414889-09-0.mol

Chemical Properties

• CAS DataBase Reference: (S)-6-chloro-1-(4-methoxybenzyl)-2-oxo-4-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-4-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-6-chloro-1-(4-methoxybenzyl)-2-oxo-4-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-4-carbonitrile(1414889-09-0)
• EPA Substance Registry System: (S)-6-chloro-1-(4-methoxybenzyl)-2-oxo-4-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-4-carbonitrile(1414889-09-0)

Safety Data

• Hazardous Substances Data: 1414889-09-0(Hazardous Substances Data)

Upstream product

• 7677-24-9 trimethylsilyl cyanide 
• 497235-37-7 6-chloro-1-[(4-methoxyphenyl)methyl]-4-(trifluoromethyl)hydroquinazolin-2-one 

Relevant articles and documents

Organocatalytic enantioselective Strecker reaction of cyclic trifluoromethyl-ketoimines

A quinine thiourea promoted enantioselective Strecker reaction of cyclic ketoimines with TMSCN has been developed. The process affords new enantioenriched trifluoromethyl dihydroquinazolinones in high yields and with high enantioselectivities. Copyright

Highly enantioselective organocatalytic Strecker reaction of cyclic N-acyl trifluoromethylketimines: Synthesis of anti-HIV drug DPC 083

A highly efficient, organocatalytic, enantioselective Strecker reaction of cyclic N-acyl ketimines was developed for the preparation of enantioenriched cyclic α-amino nitriles with a quaternary carbon stereocentre and anti-HIV drug DPC 083. This journal is

Highly enantioselective organocatalytic Strecker reaction of cyclic N-acyl trifluoromethylketimines: Synthesis of anti-HIV drug DPC 083

A highly efficient, organocatalytic, enantioselective Strecker reaction of cyclic N-acyl ketimines was developed for the preparation of enantioenriched cyclic α-amino nitriles with a quaternary carbon stereocentre and anti-HIV drug DPC 083. The Royal Society of Chemistry 2012.